Eagle Pharmaceuticals Q3 Adj. EPS $0.27 Misses $0.57 Estimate, Sales $41.147M Miss $48.49M Estimate

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.57 by 52.63 percent. This is a 77.12 percent decrease over earnings of $1.18 per share

Benzinga · 11/12/2019 11:52

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.57 by 52.63 percent. This is a 77.12 percent decrease over earnings of $1.18 per share from the same period last year. The company reported quarterly sales of $41.147 million which missed the analyst consensus estimate of $48.49 million by 15.14 percent. This is a 19.85 percent decrease over sales of $51.337 million the same period last year.